Standardized SEC financial data for MASIMO CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000937556 · NASDAQ · Electromedical & Electrotherapeutic Apparatus.
Ratios for fiscal year 2026, standardized from SEC filings.
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $1.14B | $1.24B | $2.04B | $1.28B | $1.40B | $1.53B |
| Cost of revenue | $400.7M | $430.8M | $977.0M | $509.9M | $600.9M | $581.7M |
| Gross profit | $743.0M | $808.4M | $1.06B | $765.6M |
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $645.0M | $748.4M | $209.6M | $168.2M | $181.4M | $153.3M |
| Inventory | $216.0M | $201.4M | $501.0M | $545.0M | $294.8M | $380.3M |
| Total current assets | $1.10B | $1.24B | $1.31B | $1.23B |
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Operating cash flow | $211.1M | $264.6M | $29.4M | $99.6M | $196.4M | $217.8M |
| Capital expenditures | $72.5M | $25.5M | $52.8M | $38.4M | $21.1M | $19.4M |
| Free cash flow | $138.6M | $239.1M | -$23.4M | $61.2M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MASI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MASI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $794.3M |
| $945.2M |
| R&D expense | $118.7M | $137.2M | $191.4M | $130.5M | $182.2M | $126.4M |
| SG&A expense | $369.0M | $395.4M | $657.4M | $451.3M | $548.6M | $506.0M |
| Operating income | $255.8M | $275.8M | $210.0M | $166.0M | $63.0M | $310.0M |
| EBITDA | $285.1M | $311.4M | $346.1M | $204.9M | $111.5M | $348.8M |
| Interest expense | $300K | $300K | $25.7M | $51.0M | $39.1M | — |
| Pretax income | $263.7M | $274.4M | $193.4M | $113.0M | $21.8M | $272.6M |
| Income tax | $23.4M | $44.8M | $49.9M | $5.3M | $5.6M | $64.9M |
| Net income | $240.3M | $229.6M | $143.5M | $81.5M | -$304.9M | -$151.5M |
| EPS (diluted) | $4.14 | $3.98 | $2.60 | $1.51 | $-5.60 | $-2.80 |
Standardized from MASIMO CORP's SEC filings — per-share figures split-adjusted. Full history via the API.
| $1.23B |
| $926.0M |
| Property, plant & equipment | $272.5M | $272.8M | $402.5M | $424.4M | $337.0M | $355.1M |
| Goodwill | $103.2M | $100.3M | $445.4M | $98.6M | $96.7M | $101.0M |
| Total assets | $1.71B | $1.89B | $3.21B | $3.04B | $2.63B | $1.70B |
| Total current liabilities | $233.8M | $267.7M | $630.0M | $563.8M | $617.7M | $371.6M |
| Long-term debt | — | $0 | $956.7M | $906.0M | $765.2M | $524.3M |
| Total debt | — | $0 | $971.8M | $940.3M | $780.2M | $530.6M |
| Total liabilities | $304.9M | $336.8M | $1.87B | $1.68B | $1.57B | $977.7M |
| Retained earnings | $1.34B | $1.57B | $1.71B | $1.80B | $1.49B | $1.34B |
| Total equity | $1.41B | $1.55B | $1.34B | $1.36B | $1.05B | $721.2M |
| $175.3M |
| $198.4M |
| Investing cash flow | -$82.8M | -$37.5M | -$1.06B | -$81.2M | -$51.2M | $275.1M |
| Financing cash flow | -$54.3M | -$122.4M | $520.4M | -$71.0M | -$133.4M | -$520.7M |
| Share repurchases | $110.5M | $128.9M | $401.5M | $0 | $0 | $363.7M |